CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 77% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 77% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

France leads gains for stocks; Markets await FOMC minutes

16:28 21 August 2019

Summary:

  • Strong gains seen in European indices

  • DE30: Bayer sells animal health unit

  • Wall St also firmly in the green

  • FOMC minutes due shortly (7PM BST)

 

Equity markets are surging again on Wednesday led by the French FRA40 (+2%). Those gains are followed closely by markets in Italy (+1.8%) and Germany (+1.7%) as investors return to the market among hopes for more monetary and fiscal stimulus. The Eurostoxx 50 has reached its highest level since the start of the month. After declining yesterday the markets have seemingly taken the latest political upheaval in Italy in their stride and are gaining in what is a pretty broad risk-on move.

Start investing today or test a free demo

Open account Try demo Download mobile app Download mobile app
 

Elanco Animal Health, international company focusing on veterinary drugs, reached an agreement with Bayer (BAYN.DE) on the purchase of animal health unit. Such a move is in line with Bayer’s strategy to focus on core segments like life science and pharmaceuticals. The deal is valued at $7.6 billion and it breaks down to $5.3 billion and $2.3 billion in Elanco stock. Exact stock price will be determined upon transaction closing date but early estimates hint that Bayer may acquire an up to 20% stake in Elanco through the deal. Bayer announced that it will sell the equity stake over time. Once the transaction is completed, Elanco Animal Health will become the second largest company in veterinary drugs business with Zoetis (ZTS.US) being the only bigger rival.

 

One key market to keep an eye on  is the volatility index (VOLX on xStation) which trades inversely to the S&P500. The so-called fear gauge is often seen as a proxy for and has been trading at elevated levels for much of the month. However, there are some signs that this could be subsiding and if we get much more selling in the VOLX then the backdrop for stock market gains will be more sanguine. The volatility index is trading lower by about 5% today and threatening to break below the 61.8% fib retracement of its advance at 17.31.


The economic calendar is pretty sparse today with Canadian inflation data and US Oil inventories of interest to CAD and crude traders but unlikely to have an impact outside of this. This evening sees the release of the minutes from the last FOMC decision and this has the potential to cause some moves, given that the central bank cut rates for the first time in a decade at this meeting. The cut itself was well telegraphed but any insight into the discussion behind the decision and in particular the reasons for the 2 dissenters to vote against it are key aspects to watch. With the release coming less than 48 hours before the eagerly anticipated Jackson Hole speech from chair Powell, the markets will no doubt be keenly attuned to any hints as to what the next likely step will be from the Fed.    

This content has been created by XTB S.A. This service is provided by XTB S.A., with its registered office in Warsaw, at Prosta 67, 00-838 Warsaw, Poland, entered in the register of entrepreneurs of the National Court Register (Krajowy Rejestr Sądowy) conducted by District Court for the Capital City of Warsaw, XII Commercial Division of the National Court Register under KRS number 0000217580, REGON number 015803782 and Tax Identification Number (NIP) 527-24-43-955, with the fully paid up share capital in the amount of PLN 5.869.181,75. XTB S.A. conducts brokerage activities on the basis of the license granted by Polish Securities and Exchange Commission on 8th November 2005 No. DDM-M-4021-57-1/2005 and is supervised by Polish Supervision Authority.

Back
Xtb logo

Join over 1 Million investors from around the world

We use cookies

By clicking “Accept All”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

This group contains cookies that are necessary for our websites to work. They take part in functionalities like language preferences, traffic distribution or keeping user session. They cannot be disabled.

Cookie name
Description
SERVERID
userBranchSymbol cc 2 March 2024
adobe_unique_id cc 1 March 2025
test_cookie cc 1 March 2024
SESSID cc 9 September 2022
__hssc cc 1 March 2024
__cf_bm cc 1 March 2024
intercom-id-iojaybix cc 26 November 2024
intercom-session-iojaybix cc 8 March 2024

We use tools that let us analyze the usage of our page. Such data lets us improve the user experience of our web service.

Cookie name
Description
_gid cc 9 September 2022
_gat_UA-22576382-1 cc 8 September 2022
_gat_UA-121192761-1 cc 8 September 2022
_ga_CBPL72L2EC cc 1 March 2026
_ga cc 1 March 2026
AnalyticsSyncHistory cc 8 October 2022
af_id cc 31 March 2025
afUserId cc 1 March 2026
af_id cc 1 March 2026
AF_SYNC cc 8 March 2024
__hstc cc 28 August 2024
__hssrc

This group of cookies is used to show you ads of topics that you are interested in. It also lets us monitor our marketing activities, it helps to measure the performance of our ads.

Cookie name
Description
MUID cc 26 March 2025
_omappvp cc 11 February 2035
_omappvs cc 1 March 2024
_uetsid cc 2 March 2024
_uetvid cc 26 March 2025
_fbp cc 30 May 2024
fr cc 7 December 2022
muc_ads cc 7 September 2024
lang
_ttp cc 26 March 2025
_tt_enable_cookie cc 26 March 2025
_ttp cc 26 March 2025
hubspotutk cc 28 August 2024

Cookies from this group store your preferences you gave while using the site, so that they will already be here when you visit the page after some time.

Cookie name
Description
personalization_id cc 7 September 2024
UserMatchHistory cc 8 October 2022
bcookie cc 8 September 2023
lidc cc 9 September 2022
lang
bscookie cc 8 September 2023
li_gc cc 7 March 2023

This page uses cookies. Cookies are files stored in your browser and are used by most websites to help personalise your web experience. For more information see our Privacy Policy You can manage cookies by clicking "Settings". If you agree to our use of cookies, click "Accept all".

Change region and language
Country of residence
Language